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Summary
Background Most studies of the causes of diarrhoea in low-income and middle-income countries have looked at 
severe disease in people presenting for care, and there are few estimates of pathogen-speciﬁ c diarrhoea burdens in 
the community.
Methods We undertook a birth cohort study with not only intensive community surveillance for diarrhoea but also 
routine collection of non-diarrhoeal stools from eight sites in South America, Africa, and Asia. We enrolled children 
within 17 days of birth, and diarrhoeal episodes (deﬁ ned as maternal report of three or more loose stools in 24 h, or 
one loose stool with visible blood) were identiﬁ ed through twice-weekly home visits by ﬁ eldworkers over a follow-up 
period of 24 months. Non-diarrhoeal stool specimens were also collected for surveillance for months 1–12, 15, 18, 21, 
and 24. Stools were analysed for a broad range of enteropathogens using culture, enzyme immunoassay, and PCR. 
We used the adjusted attributable fraction (AF) to estimate pathogen-speciﬁ c burdens of diarrhoea.
Findings Between Nov 26, 2009, and Feb 25, 2014, we tested 7318 diarrhoeal and 24 310 non-diarrhoeal stools collected 
from 2145 children aged 0–24 months. Pathogen detection was common in non-diarrhoeal stools but was higher with 
diarrhoea. Norovirus GII (AF 5·2%, 95% CI 3·0–7·1), rotavirus (4·8%, 4·5–5·0), Campylobacter spp (3·5%, 0·4–6·3), 
astrovirus (2·7%, 2·2–3·1), and Cryptosporidium spp (2·0%, 1·3–2·6) exhibited the highest attributable burdens of 
diarrhoea in the ﬁ rst year of life. The major pathogens associated with diarrhoea in the second year of life were 
Campylobacter spp (7·9%, 3·1–12·1), norovirus GII (5·4%, 2·1–7·8), rotavirus (4·9%, 4·4–5·2), astrovirus (4·2%, 
3·5–4·7), and Shigella spp (4·0%, 3·6–4·3). Rotavirus had the highest AF for sites without rotavirus vaccination and 
the ﬁ fth highest AF for sites with the vaccination. There was substantial variation in pathogens according to geography, 
diarrhoea severity, and season. Bloody diarrhoea was primarily associated with Campylobacter spp and Shigella spp, 
fever and vomiting with rotavirus, and vomiting with norovirus GII.
Interpretation There was substantial heterogeneity in pathogen-speciﬁ c burdens of diarrhoea, with important 
determinants including age, geography, season, rotavirus vaccine usage, and symptoms. These ﬁ ndings suggest that 
although single-pathogen strategies have an important role in the reduction of the burden of severe diarrhoeal 
disease, the eﬀ ect of such interventions on total diarrhoeal incidence at the community level might be limited. 
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Introduction
Infectious diarrhoea is the second most common cause 
of death in children under 5 years old in developing 
countries.1 Studies of the causes of diarrhoea in these 
settings have usually focused on children who present to 
health centres and, therefore, best describe pathogens 
associated with severe diarrhoea.2,3 However this 
approach captures only a small subset of diarrhoeal 
episodes which might show a diﬀ erent hierarchy of 
pathogens from that associated with mild or moderate 
episodes of diarrhoea. 
Non-severe episodes in the community are of 
substantial public health importance because of their 
high prevalence and association with poor growth, 
impaired cognitive development, environmental entero-
pathy, and even mortality.3–8 Estimates of the pathogen-
speciﬁ c burdens of diarrhoea at the community level are, 
therefore, needed to prioritise interventions. Further, 
surveillance in the community allows for unbiased 
estimates of the associations between patho gens and 
distinct clinical syndromes.
The Etiology, Risk Factors, and Interactions of Enteric 
Infections and Malnutrition and the Consequences for 
Child Health and Development Project (MAL-ED) is a 
multisite birth cohort study at eight sites in South 
America, sub-Saharan Africa, and Asia.9 We aimed to 
estimate pathogen-speciﬁ c burdens of diarrhoea in 
children aged 0–24 months at these MAL-ED study sites.
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Methods
Study design and participants
A detailed description of the MAL-ED study design is 
available elsewhere.9 We enrolled children from the 
community within 17 days of birth at eight study 
locations: Dhaka, Bangladesh; Fortaleza, Brazil; Vellore, 
India; Bhaktapur, Nepal; Loreto, Peru; Naushero Feroze, 
Pakistan; Venda, South Africa; and Haydom, Tanzania.10–17
Inclusion criteria included: a mother aged 16 years or 
older; intention for the family to stay in the study area for 
at least 6 months from enrolment; that the child was 
from a singleton pregnancy and had no other siblings 
enroled in the study; and birthweight or enrolment 
weight greater than 1500g. We excluded children with 
diagnosed congenital disease or severe neontal disease in 
the newborn. 
Enrolment took place between November, 2009, and 
February, 2012. We aimed to enrol at least 200 children at 
every site, and we staggered enrolment to capture 
approximately equal number of births in each calendar 
month. Follow-up was for 24 months. Length, weight, 
and head circumference were measured every month, as 
described previously.18
All sites received ethics approval from their respective 
governmental, local institutional, and collaborating 
institutional ethics review boards. Written informed 
consent was obtained from the parent or guardian of 
every child.
Sample and data collection
Non-diarrhoeal stool specimens were collected for 
surveillance for months 1–12, 15, 18, 21, and 24. Diarrhoeal 
episodes were collected from age 0–23 months and were 
identiﬁ ed at home visits made by ﬁ eldworkers twice a 
week. They were deﬁ ned as maternal report of three or 
more loose stools in 24 h, or one loose stool with visible 
blood.19 Discrete episodes had at least 2 intervening days 
without diarrhoea. Diarrhoeal stool specimens had to be 
collected within 48 h of an episode. When a stool sample 
was collected between two episodes of diarrhoea that met 
criteria for collection, we assigned the sample to the 
episode closest to the time of collection.
A diarrhoea severity score was calculated for every 
episode using elements derived from the Vesikari score 
(table 1).20
Dehydration was deﬁ ned as irritability that was 
diﬃ  cult to console, increased thirst, loss of skin turgor, 
sunken eyes, or lethargy.21 Dysentery was deﬁ ned as 
diarrhoea in which visible blood was reported by the 
child’s mother. Diarrhoea associated with fever was 
deﬁ ned as diarrhoea with ﬁ eldworker-conﬁ rmed 
temperature greater than 37·5°C, and vomiting-
associated diarrhoea required vomiting at any point 
during the episode of diarrhoea.
Diarrhoeal episodes of fewer than 7 days’ duration were 
classiﬁ ed as acute, 7–14 days as prolonged, and more 
than 14 days as persistent. Stools collected within 1 day of 
administration of a lactulose-mannitol test were excluded 
from analysis.22 Data on rotavirus vaccine administration 
and antibiotic use were recorded and children were 
referred to medical care for severe symptoms.23,24
 Stool testing
All stools were analysed in accordance with a standardised 
microbiology protocol, which was implemented at all 
1 point 2 points 3 points
Duration 2–4 days 5–7 days ≥8 days
Maximum number of loose 
stools in 24 h
<5 loose stools 5–7 loose stools >7 loose stools
Days of vomiting 1 day 2 days >2 days
Presence of dehydration ·· Some dehydration Severe dehydration
Fever Maternal report of 
fever
·· Temperature >37·5°C 
conﬁ rmed by ﬁ eld worker
Elements derived from the Vesikari score20
Table 1: Scoring system for diarrhoea severity score
Research in context
Evidence before this study
We searched PubMed for articles published in any language 
since 1990 using the terms “diarrhea/diarrhoea” and “etiology/
aetiology” and “pediatric/paediatric OR infant*” and “case-
control study OR cohort study.” We identiﬁ ed 482 publications, 
including 11 aetiologic studies of diarrhoea which included 
testing for a broad range of enteropathogens. Of t hose, eight 
studied children with more severe diarrhoea presenting to 
health-care settings. The three remaining studies of community 
diarrhoea involved a single site. 
Added value of this study
Our study provides multisite data on the causes of diarrhoea 
with longitudinal surveillance and interrogation of a broad 
range of pathogens, allowing unbiased estimates of pathogen-
speciﬁ c burdens of diarrhoea in the community as well as 
estimates for speciﬁ c diarrhoeal syndromes. It documents the 
broad range of pathogens associated with diarrhoea of any 
severity, the heterogeneity of the main causes of diarrhoea in 
low-income and middle-income countries, and the diversity of 
pathogens associated with seasonal peaks. It also documents 
the eﬀ ect of rotavirus vaccine.
Implications of all available evidence
These data suggest that the causes of community diarrhoea are 
diverse, and single pathogen interventions might not have a 
substantial impact on total diarrhoeal incidence across multiple 
populations.
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study sites and has been described in detail previously.25 
We used conventional stool culture to identify bacterial 
pathogens with the exception of Campylobacter spp.
Testing for diarrhoeagenic Escherichia coli was done by 
pooling ﬁ ve lactose-fermenting colonies for multiplex 
PCR to detect the toxin-encoding genes stx1, stx2, eae, 
bfpA, ipaH, aatA, and aaiC, as well as those encoding heat-
labile enterotoxin (LT) and heat-stable enterotoxin (ST).
Enzyme immunoassay was used for detection of 
Campylobacter spp, rotavirus, adenovirus, and astrovirus 
(ProSpecT, Remel, Lenexa, KS, USA) and 
Entamoeba histolytica, Giardia spp, and Crypto-
sporidium spp (TechLab, Blacksburg, VA, USA). Rotavirus 
detections were considered negative if obtained within 
28 days of rotavirus vaccine administration (n=18).
We used PCR to test all diarrhoeal stool samples for 
norovirus. We also aimed to test all non-diarrhoeal stool 
samples from a randomly selected 10% subset of 
participants at each site.
If an additional specimen was available, we did use 
microscopy for identiﬁ cation of protozoa and helminths; 
however, microscopy was not required for com plete testing, 
and microscopy results were not included for the analysis 
of infections for the three protozoal pathogens tested by 
enzyme immunoassay. If testing was incomplete, 
recollection was allowed within 48 h.
Statistical analysis
Because pathogens were frequently detected in diarrhoeal 
and non-diarrhoeal stools, we used the adjusted 
attributable fraction (AF) to estimate pathogen-speciﬁ c 
Children 
enrolled
Diarrhoea 
episodes 
reported
Diarrhoea 
episode 
stools 
collected
Diarrhoeal 
stools 
completely 
tested
Surveillance 
stools 
collected
Surveillance 
stools 
completely 
tested
Completely tested diarrhoeal stool samples for speciﬁ c syndromes
Acute 
(<7 days)
Prolonged 
(≥7 days)
Mild 
(score 1–3)
Moderate 
(score 4–6)
Severe 
(score >6)
Blood in 
stool
Associated 
fever
Associated 
vomiting
Dhaka, 
Bangladesh
265 1684 1591 1526
(95·9%)
2937 2910
(99·1%)
1350
(88·5%)
176
(11·5%)
753
(49·3%)
574
(37·6%)
199
(13·0%)
64
(4·2%)
48
(3·2%)
477
(31·3%)
Vellore, India 251 982 749 698
(93·2%)
3215 3181
(98·9%)
611
(87·5%)
87
(12·5%)
406
(58·2%)
218
(31·2%)
74
(10·6%)
49
(7·0%)
13
(1·9%)
164
(23·5%)
Bhaktapur, 
Nepal
240 1083 976 925
(94·8%)
3105 3071
(98·9%)
684
(74·0%)
241
(26·1%)
266
(28·8%)
525
(56·8%)
134
(14·5%)
43
(4·7%)
58
(6·3%)
179
(19·4%)
Naushero 
Feroze, 
Pakistan
277 3255 2272 1836
(80·8%)
2820 2777
(98·5%)
1182
(64·4%)
654
(35·6%)
498
(27·1%)
770
(41·9%)
568
(30·9%)
60
(3·3%)
91
(5·0%)
641
(34·9%)
Venda, South 
Africa
314 324 200 157
(78·5%)
3720 3617
(97·2%)
149
(94·9%)
8
(5·1%)
122
(77·7%)
32
(20·4%)
3
(1·9%)
4
(2·6%)
4
(2·6%)
28
(17·8%)
Haydom, 
Tanzania
262 625 206 171
(83·0%)
3295 3252
(98·7%)
158
(92·4%)
13
(7·6%)
95
(55·6%)
63
(36·8%)
13
(7·6%)
27
(15·8%)
0 63
(36·8%)
Fortaleza, 
Brazil
233 188 129 117
(90·7%)
2519 2425
(96·3%)
99
(84·6%)
18
(15·4%)
73
(62·4%)
34
(29·1%)
10
(8·6%)
2
(1·7%)
12
(10·3%)
34
(29·1%)
Loreto, Peru 303 2131 2047 1888
(92·2%)
3185 3077
(96·6%)
1584
(83·9%)
304
(16·1%)
1038
(55·0%)
650
(34·4%)
200
(10·6%)
108
(5·7%)
120
(6·4%)
347
(18·4%)
Total 2145 10272 8170 7318
(89·6%)
24 796 24 310
(98·0%)
5817
(79·5%)
1501
(20·5%)
3251
(44·4%)
2866
(39·1%)
1201
(16·4%)
357
(4·9%)
346
(4·7%)
1933
(26·4%)
Table 2: MAL-ED cohort descriptive statistics and completeness of surveillance and testing
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Figure 1: Pathogens detected in diarrhoeal and non-diarrhoeal stools, 0–11 months and 12–24 months
EAEC=enteroaggregative Escherichia coli; EIEC=enteroinvasive E coli; aEPEC=atypical enteropathogenic E coli; 
tEPEC=typical enteropathogenic E coli; LT-ETEC=LT-producing enterotoxigenic E coli; ST-ETEC=ST-producing 
enterotoxigenic E coli; STEC=Shiga-toxin-producing E coli. Pathogens present in less than 0.1% of stool samples are 
not shown.
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burdens of diarrhoea, a measurement that incorporates 
the prevalence of detection in diarrhoeal stools and the 
strength of association with diarrhoea.
To analyse the strength of association between 
diarrhoea and detection of individual pathogens, we used 
generalised estimating equations (GEEs) to ﬁ t a binary 
logistic regression model for each site and age group to 
account for non-independence of stool testing within 
each participant. All models were adjusted for age (in 
days), sex, and site. We included all detected pathogens 
from diarrhoeal stools for each age and site, and we 
assumed an independent working correlation matrix. We 
then calculated AFs using the point estimate of the odds 
ratios derived from the multivariate GEEs26,27 with 
95% CIs estimated using the Delta method.28
We determined the pathogen-speciﬁ c attributable 
incidence for each calendar month by ﬁ rst calculating 
the AF using the prevalence of each pathogen in 
diarrhoea for each calendar month and then multiplying 
by the number of episodes of diarrhoea during that 
month. To mitigate the detection of convalescent 
excretion of pathogens, we excluded from analysis non-
diarrhoeal stools collected more than 48 h but fewer than 
7 days before or after a diarrhoeal episode. The eﬀ ect of 
prolonged excretion of enteric pathogens on AF estimates 
was evaluated by further restricting non-diarrhoeal 
specimens to those collected at least 28 days before and 
after any diarrhoeal episode. Pathogen-speciﬁ c AFs were 
calculated for the subset of diarrhoeal episodes that met 
study deﬁ nitions of acute, prolonged, persistent, mild, 
moderate, severe, or dysenteric diarrhoea, or diarrhoea 
associated with fever or with vomiting.
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Figure 2: Pathogen detection and diarrhoeal episodes per child, 0–24 months
Dots show mean values with standard error bars.
Dhaka,
Bangladesh
Vellore,
India
Bhaktapur,
Nepal
Naushero 
Feroze,
Pakistan
Venda,
South Africa*
Haydom,
Tanzania
Fortaleza,
Brazil*
Loreto,
Peru*
Overall
Age 0–11 months
Diarrhoeal stools 819 419 524 1230 84 145 38 1021 4280
Non-diarrhoeal stools 2194 2252 2264 1902 2665 2391 1747 2354 17 769
Norovirus GII ·· ·· 8·4%
(5·7–9·7)
·· ·· 8·2%
(0·5–12·9)
·· 5·1%
(0·2–9·1)
5·2%
(3·0–7·1)
Rotavirus 9·6%
(8·8–10·1)
6·0%
(5·5–6·3)
6·6%
(5·9–6·9)
3·2%
(2·6–3·5)
·· 9·5%
(7·6–10·5)
·· 1·0%
(0·0–1·6)
4·8%
(4·5–5·0)
Campylobacter spp ·· ·· ·· ·· 16·9%
(9·0–21·6)
·· 30·9%
(22·8–34·3)
5·6%
(0·7–9·5)
3·5%
(0·4–6·3)
Astrovirus 2·0%
(0·3–3·2)
4·2%
(3·2–4·9)
·· 2·2%
(0·9–3·1)
·· ·· ·· 3·6%
(2·7–4·3)
2·7%
(2·2–3·1)
Cryptosporidium spp ·· ·· ·· 3·6%
(1·9–4·8)
·· 6·3%
(1·2–9·1)
5·5%
(0·0–7·2)
2·6%
(0·6–4·1)
2·0%
(1·3–2·6)
ST–ETEC 4·7%
(3·3–5·8)
1·7%
(0·6–2·3)
2·0%
(1·0–2·5)
1·2%
(0·1–1·8)
3·3%
(0·9–4·2)
·· ·· ·· 1·9%
(1·5–2·2)
Adenovirus ·· 2·7%
(0·9–3·7)
2·3%
(0·7–3·2)
1·1%
(0·0–1·9)
·· ·· ·· 1·5%
(0·2–2·3)
1·6%
(1·0–2·0)
tEPEC 2·2%
(0·0–4·1)
·· ·· ·· ·· ·· ·· ·· 1·3%
(0·7–1·9)
LT–ETEC 2·0%
(0·2–3·3)
·· ·· ·· ·· ·· 16·9%
(11·1–19·3)
·· 1·3%
(0·6–1·9)
(Table 3 continues on next page)
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To analyse the association between pathogen 
detection and diarrhoea severity, GEEs were used to ﬁ t 
an ordinal regression model which was speciﬁ ed 
identically to the logistic regression models used for 
the analysis of diarrhoea association. For all analyses, 
we constructed models both with and without norovirus 
because of the diﬀ erential testing of non-diarrhoeal 
specimens for this pathogen. The results we report for 
pathogens other than norovirus, as well as for all 
analyses involving aggregated pathogen testing, were 
derived from models that excluded norovirus. We used 
R version 3.0.3 (Foundation for Statistical Computing, 
Vienna, Austria) for all statistical analyses, with the 
geepack package within this program used for GEE 
analysis.29
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had ﬁ nal responsibility for 
the decision to submit for publication.
Results
Between Nov 3, 2009, and Febm29, 2012, we enrolled 
2145 children (range 233–314 per site). The size of the 
Dhaka,
Bangladesh
Vellore,
India
Bhaktapur,
Nepal
Naushero 
Feroze, 
Pakistan
Venda,
South Africa*
Haydom,
Tanzania
Fortaleza,
Brazil*
Loreto,
Peru*
Overall
(Continued from previous page)
Shigella spp ·· ·· 0·7%
(0·3–0·7)
0·9%
(0·6–1·1)
·· ·· ·· ·· 0·4%
(0·2–0·5)
Age 12–24 months
Diarrhoeal stools 707 279 401 606 73 26 79 867 3038
Non-diarrhoeal stools 716 929 807 875 952 861 678 723 6541
Campylobacter spp ·· ·· 8·8%
(2·0–13·8)
·· ·· ·· ·· 9·9%
(3·0–15·5)
7·9%
(3·1–12·1)
Norovirus GII ·· ·· 11·2%
(6·4–11·9)
·· 19·2%
(2·2–26·3)
·· ·· 11·7%
(6·0–15·2)
5·4%
(2·1–7·8)
Rotavirus 6·0%
(4·8–6·6)
4·8%
(4·0–5·2)
8·7%
(8·7–8·7)
2·2%
(0·7–2·9)
·· 14·3%
(11·5–15·1)
4·3%
(1·7–4·9)
2·9%
(0·8–4·2)
4·9%
(4·4–5·2)
Astrovirus 2·6%
(0·7–3·7)
3·1%
(1·7–3·7)
4·6%
(3·2–5·3)
·· ·· 9·7%
(1·8–11·2)
4·7%
(3·2–5·0)
7·4%
(5·5–8·6)
4·2%
(3·5–4·7)
Shigella spp 1·5%
(0·3–2·0)
9·4%
(8·7–9·8)
6·8%
(5·8–7·4)
5·1%
(3·8–5·9)
·· ·· 3·7%
(2·1–3·8)
2·1%
(0·8–2·7)
4·0%
(3·6–4·3)
ST–ETEC 8·0%
(5·6–9·7)
5·4%
(3·6–6·3)
4·6%
(2·2–5·9)
·· ·· 9·1%
(2·7–10·9)
·· 2·0%
(0·5–2·7)
3·9%
(3·1–4·5)
Cryptosporidium spp 2·5%
(0·0–4·0)
6·9%
(5·3–7·7)
3·2%
(1·4–4·1)
5·5%
(3·5–6·8)
·· 13·0%
(6·9–14·7)
·· ·· 3·8%
(2·8–4·7)
LT–ETEC 2·4%
(0·1–3·8)
·· ·· ·· ·· 16·1%
(0·0–22·8)
·· ·· 1·2%
(0·0–2·1)
Adenovirus ·· 3·6%
(0·9–5·0)
3·9%
(2·1–4·8)
·· ·· ·· 3·8%
(1·1–4·7)
·· 0·9%
(0·0–1·8)
EIEC ·· ·· 1·2%
(0·0–1·6)
·· ·· ·· ·· ·· 0·8%
(0·1–1·2)
Entamoeba histolytica ·· 0·7%
(0·7–0·7)
·· 0·8%
(0·2–1·1)
·· ·· ·· ·· 0·7%
(0·3–0·9)
Salmonella ·· 0·7%
(0·7–0·7)
0·5%
(0·5–0·5)
·· ·· ·· ·· 0·5%
(0·5–0·5)
0·3%
(0·0–0·5)
Norovirus GI ·· ·· 1·0%
(1·0–1·0)
·· ·· ·· ·· ·· ··
Aeromonas ·· ·· ·· ·· ·· ·· ·· 1·0%
(0·1–1·2)
··
Plesiomonas ·· 0·7%
(0·7–0·7)
·· ·· ·· ·· ·· ·· ··
STEC ·· ·· ·· ·· ·· ·· ·· 0·2%
(0·2–0·2)
··
EIEC=enteroinvasive Escherichia coli; tEPEC=typical enteropathogenic E coli; LT-ETEC=LT-producing enterotoxigenic E coli; ST-ETEC=ST-producing enterotoxigenic E coli; 
STEC=Shiga-toxin producing E coli. Data are n or attributable fractions (95% CI). For cells with ··, the pathogen was either not detected or was not statistically signiﬁ cantly 
associated with diarrhoea (appendix). *Monovalent rotavirus vaccine was introduced to the national immunisation programme at these sites before the study began.
Table 3: Adjusted attributable fraction of diarrhoea for individual pathogens in the ﬁ rst and second year of life
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cohort at each site and completeness of stool testing is 
shown in table 2.  We recorded 2 years of follow-up data 
for 1740 participants (81·1%).
Two ﬁ eldworker visits per week were suﬃ  cient to collect 
most diarrhoeal stools within 48 h (79·5% overall; site 
range 33·0–96·1%). Collection rates were higher for 
longer episodes (75·5% for acute episodes and 99·3% for 
prolonged or persistent episodes).
A broad range of pathogens was detected, with 
22 pathogens in the ﬁ rst year of life and 25 in the second 
year of life (we have not included pathogens in analysis if 
they were present in only very few samples—ie, less than 
0·1% of all stools). For certain pathogens, detection in non-
diarrhoeal stools approached, and in some cases exceeded, 
that noted for diarrhoeal stools (ﬁ gure 1).
Enteropathogen infection began soon after birth and 
was common at all sites; however, the intensity varied 
between sites, ranging from an average of about 
0·5 pathogens detected per stool by the end of the ﬁ rst 
year of life (South Africa) to almost two pathogens per 
stool (Pakistan; ﬁ gure 2). Both the incidence of diarrhoea 
and the number of pathogens detected per stool 
increased markedly during the ﬁ rst year of life. At least 
one pathogen was detected in 76·9% (n= 15767) of 
diarrhoeal stools and 64·9% (15767) of non-diarrhoeal 
stools, and two or more pathogens were identiﬁ ed in 
41·0% (2999) and 29·0% (7046) of stools, respectively. 
The number of pathogens detected was higher in 
diarrhoeal stools than non-diarrhoeal stools at most time 
points (appendix).
The presence of pathogens was associated with diarrhoea, 
in that each additional pathogen increased the odds of 
diarrhoea (odds ratio (OR) 1·20 per pathogen detection, 
p<0·0001]). Antibiotics were administered for 4696 (46%) 
diarrhoeal episodes captured by surveillance  with a range 
between sites of 20 (11%, Brazil) to 1922 (59%, Pakistan). 
 Overall, 19·1%, (95% CI 16·2–21·8) and 33·1% 
(29·0–36·7) of diarrhoeal episodes in the ﬁ rst and second 
year of life, respectively, could be attributed to pathogens. 
Attributable fractions did not change appreciably when 
the more restrictive deﬁ nition of non-diarrhoeal 
specimens was applied, suggesting that estimates were 
not biased by convalescent excretion (appendix), nor did 
they change after controlling for child nutritional status 
(height-for-age Z score).
Across all sites and episodes, the highest AFs were 
seen for norovirus GII, rotavirus, Campylobacter spp, 
astrovirus, and Cryptosporidium spp in the ﬁ rst year of life 
and Campylobacter spp, norovirus GII, rotavirus, 
astrovirus, and Shigella spp in the second year of life 
(table 3 and appendix).
There was substantial heterogeneity between sites in 
the individual pathogen most often associated with 
diarrhoea, with the highest burden of diarrhoea attributed 
to four unique pathogens in the ﬁ rst year of life 
(Campylobacter spp, Cryptosporidium spp, norovirus GII, 
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Figure 3: Prevalence and adjusted attributable fraction of diarrhoea for 3-month intervals, age 0–24 months
EAEC=enteroaggregative Escherichia coli; EIEC=enteroinvasive E coli; aEPEC=atypical enteropathogenic E coli; tEPEC=typical enteropathogenic E coli; LT-ETEC=LT-
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and rotavirus) and six across the eight sites in the second 
year of life (astrovirus, Cryptosporidium spp, LT-producing 
enterotoxigenic E coli, norovirus GII, Shigella spp, and ST-
producing entero toxigenic E coli; table 3) . The monovalent 
rotavirus vaccine was introduced in three participating 
countries (South Africa, Brazil, and Peru) before the 
study began, with 89·4% of enrolled children receiving at 
least one dose at those sites. The eﬀ ect of rotavirus 
vaccine was evident, in that rotavirus had the highest 
overall AF at sites without rotavirus vaccination (AF 5·8%, 
95% CI 5·6–6·0) and the ﬁ fth highest overall AF at sites 
with rotavirus vaccination (1·9%, 1·0–2·6).
Three frequently detected pathogens, namely entero-
aggregative E coli, Giardia spp, and atypical entero-
pathogenic E coli, were not statistically signiﬁ cantly 
associated with diarrhoea for any age group, site, or 
diarrhoeal syndrome. Age-related patterns were seen for 
several pathogens: astrovirus, norovirus GII, and rotavirus 
diarrhoea burdens peaked during age 6–12 months, 
whereas Cryptosporidium spp, Shigella spp, 
Campylobacter spp, and ST-producing enterotoxigenic 
E coli continued to increase through the second year of life 
(ﬁ gure 3). First infections were more strongly associated 
with diarrhoea than were subsequent infections for most 
pathogens; however, this did not alter AF estimates (data 
not shown). Helmintic infections were not associated with 
diarrhoea for any age group, site, or diarrhoeal syndrome.
We next examined whether clinical characteristics or 
seasonality could aid prediction of the cause of diarrhoea. 
Total attribution to pathogens for episodes associated 
with dysentery, dehydration, or admission to hospital was 
33·4% (95% CI 27·1–38·6) and 29·1% (26·6–31·0%) in 
the ﬁ rst and second year of life, respectively, and 
pathogens most often associated with these events were 
rotavirus, Campylobacter spp, and norovirus GII in the 
ﬁ rst year and Shigella spp, rotavirus, and ST-producing 
enterotoxigenic E coli in the second year of life (appendix). 
Campylobacter, Shigella spp, and enteroinvasive E coli were 
associated with the highest burden of dysentery (table 4). 
Pathogens associated with fever included rotavirus and 
Shigella spp. Rotavirus and norovirus GII were the 
pathogens most often associated with vomiting.
Use of the diarrhoea severity score that incorporated 
vomiting, fever, frequency, and dehydration showed that 
the following were associated with a higher severity score: 
rotavirus (OR 2·30 per one unit increase in severity score, 
95% CI 1·91–2·77; p<0·0001), Shigella spp (1·48, 
1·13–1·93; p=0·0043), adenovirus (1·45, 1·19–1·78; 
Acute 
(<7 days)
Prolonged 
(≥7 days)
Mild 
(score 1–3)
Moderate 
(score 4–6)
Severe 
(score >6)
Blood in 
stool
Associated 
fever
Associated 
vomiting
Overall
Age 0–11 months
Diarrhoeal stools 
(% of diarrhoea)
3249 
(75·9%)
1031 
(24·1%)
1696 
(39·6%)
1762 
(41·2%)
820 (19·2%) 198 (4·6%) 204 (4·8%) 1235 
(28·9%)
4280
Norovirus GII 5·5%
(3·1–7·5)
4·4%
(0·9–7·2)
5·2%
(2·5–7·6)
4·7%
(2·0–7·0)
5·5%
(1·8–8·5)
·· ·· 7·5%
(4·5–10·0)
5·2%
(3·0–7·1)
Rotavirus 5·6%
(5·3–5·8)
2·2%
(1·7–2·6)
2·0%
(1·5–2·3)
5·2%
(4·9–5·5)
9·8%
(9·5–10·1)
·· 7·2%
(6·3–7·7)
11·1%
(10·8–11·4)
4·8%
(4·5–5·0)
Campylobacter spp 4·4%
(1·1–7·3)
·· 8·1%
(4·3–11·4)
·· ·· 23·7%
(14·2–30·3)
·· ·· 3·5%
(0·4–6·3)
Astrovirus 2·9%
(2·4–3·4)
1·8%
(0·8–2·5)
2·7%
(2·0–3·2)
2·3%
(1·6–2·9)
3·4%
(2·4–4·1)
·· ·· 3·9%
(3·1–4·5)
2·7%
(2·2–3·1)
Cryptosporidium spp 1·7%
(0·9–2·4)
3·0%
(1·8–4·0)
1·2%
(0·0–2·0)
2·3%
(1·3–3·1)
3·1%
(1·5–4·2)
·· ·· 2·4%
(1·1–3·4)
2·0%
(1·3–2·6)
ST-ETEC 2·4%
(1·9–2·7)
·· 1·8%
(1·2–2·3)
2·2%
(1·7–2·6)
1·4%
(0·5–2·0)
·· ·· 1·9%
(1·2–2·5)
1·9%
(1·5–2·2)
Adenovirus 1·4%
(0·8–1·9)
2·1%
(1·2–2·7)
1·0%
(0·3–1·5)
1·6%
(0·9–2·2)
3·2%
(2·2–3·9)
·· 3·0%
(0·9–4·1)
3·1%
(2·2–3·7)
1·6%
(1·0–2·0)
tEPEC 1·2%
(0·4–1·8)
1·6%
(0·5–2·5)
1·4%
(0·4–2·2)
·· 2·2%
(0·8–3·2)
·· ·· 1·5%
(0·2–2·5)
1·3%
(0·7–1·9)
LT-ETEC 0·9%
(0·1–1·6)
2·6%
(1·4–3·4)
1·0%
(0·0–1·8)
1·1%
(0·1–1·9)
2·3%
(0·9–3·3)
·· ·· 1·8%
(0·6–2·8)
1·3%
(0·6–1·9)
Shigella spp 0·3%
(0·1–0·4)
0·6%
(0·3–0·7)
0·3%
(0·1–0·4)
0·4%
(0·2–0·5)
·· 3·4%
(3·1–3·5)
1·2%
(0·5–1·4)
·· 0·4%
(0·2–0·5)
STEC ·· 0·5%
(0·0–0·7)
·· ·· ·· ·· ·· ·· ··
EIEC ·· ·· ·· ·· 0·8%
(0·4–1·0)
1·7%
(0·4–2·2)
·· ·· ··
Salmonella spp ·· ·· ·· ·· 0·6%
(0·1–0·9)
·· 1·5%
(0·6–1·8)
·· ··
Entamoeba histolytica ·· ·· ·· ·· ·· ·· 1·3%
(0·0–1·7)
·· ··
(Table 4 continues on next page)
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p=0·0003), and Cryptosporidium spp (1·26, 1·07–1·49; 
p=0·0065). Campylobacter spp were associated with a 
lower score (0·85, 0·77–0·94; p=0·0011) .
Persistent diarrhoea represented 4·9% and 1·8% of 
episodes during the ﬁ rst and second year of life, respectively, 
and was associated with LT-producing enterotoxigenic E coli, 
astrovirus, Cryptosporidium spp, ST-producing entero toxi-
genic E coli, and Shigella spp in the ﬁ rst year of life and 
Shigella and astrovirus in the second (data not shown).
The association between the attributable incidence of 
speciﬁ c pathogens and seasonal diarrhoeal incidence 
varied between sites (ﬁ gure 4). For many sites, peak 
diarrhoeal incidence coincided with the peak attributable 
incidence for some pathogens—for example Crypto-
sporidium spp, ST-producing entero toxigenic E coli, 
Shigella spp, and astrovirus in India and norovirus GII, ST-
producing enterotoxigenic E coli, and Shigella spp in Nepal. 
Rotavirus incidence was strongly seasonal, and during 
peak season it dominated all-cause diarrhoea incidence in 
India, Nepal, Pakistan, and Tanzania. There was little 
association between rotavirus incidence and seasonality at 
the three sites where rotavirus vaccine had been introduced.
Discussion
In this multicountry community-based cohort study, 
pathogen-speciﬁ c burdens of diarrhoea varied sub stantially 
between sites. Although rotavirus diarrhoea burden was 
substantially decreased at sites where rotavirus vaccine had 
been introduced, it occupied the overall highest burden of 
disease at the ﬁ ve sites that do not have vaccination. 
Nevertheless, it was associated with the highest burden of 
diarrhoea at only three sites in the ﬁ rst year of life and at 
none in the second year. Cryptosporidium spp, ST-producing 
enterotoxigenic E coli, and Shigella spp were also associated 
with more severe  diarrhoea than were other pathogens and 
are well known to be important pathogens.2,3 Additionally, 
however, a substantial number of diarrhoeal episodes were 
attributable to Campylobacter spp, norovirus GII, and 
Acute 
(<7 days)
Prolonged 
(≥7 days)
Mild 
(score 1–3)
Moderate 
(score 4–6)
Severe 
(score >6)
Blood in 
stool
Associated 
fever
Associated 
vomiting
Overall
(Continued from previous page)
Age 12–24 months
Diarrhoeal stools 
(% of diarrhoea)
2568 
(84·5%)
470
(15·5%)
1553
(51·1%)
1104 
(36·3%)
381
(12·5%)
159
(5·2%)
142
(4·7%)
698
(23·0%)
3038
Campylobacter spp 8·9%
(4·0–13·2)
·· 9·7%
(3·9–14·7)
8·3%
(1·8–13·9)
·· ·· ·· ·· 7·9%
(3·1–12·1)
Norovirus GII 5·1%
(1·8–7·6)
6·9%
(1·4–10·4)
4·5%
(0·7–7·3)
6·2%
(2·3–9·0)
6·9%
(1·3–10·4)
·· ·· 8·9%
(4·9–11·7)
5·4%
(2·1–7·8)
Rotavirus 5·2%
(4·7–5·6)
2·9%
(1·9–3·4)
3·8%
(3·2–4·3)
5·1%
(4·5–5·5)
7·9%
(7·2–8·4)
·· 4·9%
(3·4–5·7)
10·1%
(9·6–10·5)
4·9%
(4·4–5·2)
Astrovirus 4·5%
(3·8–5·0)
2·3%
(0·9–3·2)
4·1%
(3·2–4·7)
4·7%
(3·9–5·3)
2·8%
(1·1–3·7)
·· 5·4%
(3·2–6·6)
4·5%
(3·5–5·2)
4·2%
(3·5–4·7)
Shigella spp 3·4%
(3·0–3·7)
7·0%
(6·4–7·4)
2·7%
(2·2–3·0)
5·1%
(4·6–5·5)
5·7%
(5·0–6·1)
17·2%
(16·5–17·6)
6·9%
(6·0–7·3)
3·1%
(2·4–3·4)
4·0%
(3·6–4·3)
ST-ETEC 3·6%
(2·8–4·3)
5·5%
(4·1–6·4)
3·4%
(2·5–4·2)
3·9%
(2·8–4·8)
5·8%
(4·4–6·8)
·· 3·6%
(0·6–5·0)
5·5%
(4·4–6·3)
3·9%
(3·1–4·5)
Cryptosporidium spp 3·4%
(2·2–4·3)
6·1%
(4·1–7·4)
3·0%
(1·6–4·2)
4·5%
(3·1–5·6)
3·2%
(0·5–4·9)
·· ·· 3·8%
(1·8–5·1)
3·8%
(2·8–4·7)
LT-ETEC 1·3%
(0·1–2·3)
·· ·· 1·5%
(0·0–2·8)
·· ·· 5·0%
(1·2–7·1)
2·2%
(0·3–3·4)
1·2%
(0·0–2·1)
Adenovirus 1·0%
(0·2 –1·9)
·· 0·8%
(0·1–1·3)
1·9%
(0·4–3·0)
·· ·· ·· 1·9%
(0·0–3·1)
0·9%
(0·0–1·8)
EIEC 0·8%
(0·1–1·3)
·· 0·9%
(0·5–1·1)
1·2%
(0·2–1·8)
·· 5·0%
(3·2–5·8)
·· ·· 0·8%
(0·1–1·2)
E histolytica 0·7%
(0·3–0·9)
·· 1·1%
(0·7–1·3)
·· ·· ·· ·· ·· 0·7%
(0·3–0·9)
Salmonella 0·4%
(0·1–0·5)
·· 0·4%
(0·1–0·5)
·· ·· ·· 1·8%
(1·1–2·0)
·· 0·3%
(0·0–0·5)
Aeromonas spp ·· ·· ·· ·· ·· 3·3%
(1·0–4·3)
·· ·· ··
Plesiomonas spp ·· ·· ·· ·· ·· 1·2%
(0·0–1·6)
·· ·· ··
EIEC=enteroinvasive Escherichia coli; tEPEC=typical enteropathogenic E coli; LT-ETEC=LT-producing enterotoxigenic E coli; ST-ETEC=ST-producing enterotoxigenic E coli; 
STEC=Shiga-toxin producing E coli. Data are n or attributable fractions (95% CI). The subset of pathogens assayed that were signiﬁ cant in at least one syndrome or age group 
are shown in descending order of average attributable fraction for study-deﬁ ned diarrhoea. For cells with a dash, the pathogen was either not detected or was not statistically 
signiﬁ cantly associated with diarrhoea. 
Table 4: Adjusted attributable fraction of diarrhoea associated with speciﬁ c diarrhoeal syndromes in the ﬁ rst and second year of life for individual pathogens 
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astrovirus—pathogens that have rarely been examined in 
such a large study with modern diagnostic tools,2 or have 
not been noted as important in case-control studies.2,3,30 The 
number and diversity of pathogens associated with 
community diarrhoea suggests that single pathogen 
interventions, apart from rotavirus vaccination, might not 
have an eﬀ ect on the incidence of diarrhoeal episodes 
across populations.
This multisite longitudinal study design allowed us to 
uncover an unbiased picture of the association between 
speciﬁ c pathogens and speciﬁ c clinical features, including 
duration, severity, dysentery, febrile illness, and vomiting. 
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Figure 4: Association between individual pathogens and seasonal diarrhoeal incidence
tEPEC=typical enteropathogenic Escherichia coli; LT-ETEC=LT-producing enterotoxigenic E coli; ST-ETEC=ST-producing enterotoxigenic E coli. Primary y-axis shows percent of total attributable incidence 
of diarrhoea for individual pathogens; secondary y-axis (and dotted line) shows annual diarrhoeal incidence by calendar month. *Monovalent rotavirus vaccine was introduced to the national 
immunisation programme before the study began.
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Dysentery in the ﬁ rst year of life was predominantly 
associated with Campylobacter spp; however, Campylobacter-
associated diarrhoea was, otherwise, mild when assessed 
with a severity score that did not include the presence of 
blood. By contrast, dysentery associated with Shigella spp 
was often severe and of surprisingly long duration. 
Rotavirus and norovirus GII were associated with vomiting.
Campylobacter spp were the most frequently detected 
pathogens and had the highest burden of diarrhoea in 
Brazil, Peru, and South Africa in the ﬁ rst year of life. Such 
a high burden of Campylobacter spp early in the ﬁ rst year 
of life, often with dysentery, has been observed in some 
studies but not others.2 This pathogen did not show 
strong seasonal trends. We have previously shown that 
culture substantially underdetects Campylobacter31 
whereas EIA broadly detects Campylobacter spp, including 
species other than C jejuni and C coli. We expect most of 
the episodes associated with Campylobacter spp to be 
caused by C jejuni or C coli, but culture identiﬁ cation was 
only done on a subset of stools in our study and further 
work is needed.
We documented a substantial burden of diarrhoea 
associated with norovirus GII infection at the sites in 
Nepal, South Africa, Tanzania, and Peru, as well as in the 
overall analysis. As in developed countries,32 norovirus 
GII appeared to be a signiﬁ cant contributor to overall 
diarrhoeal incidence at several sites. There has been 
substantial variation in previous estimates of the global 
burden of norovirus, in part because detection of 
norovirus GII is often high in asymptomatic control 
participants matched for age, community, and season.30
Astrovirus is known to be a common cause of sporadic 
diarrhoea that is less severe than that associated with 
rotavirus, and astrovirus often exists as a co-infection.33,34 
Our study shows the global importance of astrovirus 
diarrhoea, with a substantial burden of disease in most 
sites. Adenovirus had a low overall attributable fraction, 
but, when present, was associated with diarrhoea 
classiﬁ ed as “severe” by an adapted Vesikari score. We 
used a pan-adenovirus ELISA without typing for the 
major gastrointestinal subtypes 40/41; however, we would 
not expect the AF for adenovirus to increase signiﬁ cantly 
given its low prevalence. Helminth infections were rare 
in this study, except for Ascaris in the second year of life, 
and were not associated with diarrhoea.
This study also documents frequent detection of a wide 
range of pathogens, including Campylobacter spp, 
enteroaggregative E coli, norovirus, Giardia, LT-producing 
entero toxigenic E coli, and typical and atypical entero-
pathogenic E coli in routinely collected non-diarrhoeal 
stools. Whether the presence of these pathogens is 
associated with more insidious phenotypes such as poor 
growth, impaired cognitive development, environmental 
enteropathy, or impaired mucosal immunity is unclear 
and further study is warranted in this area.
Our study has some limitations. In light of the variation 
between sites in diarrhoeal incidence, the study was not 
powered to identify all associations between pathogens 
and diarrhoea at individual sites. Furthermore, because 
short episodes of diarrhoea are more diﬃ  cult to capture 
with community-based surveillance than are longer 
periods of diarrhoea, especially in rural settings, burden 
estimates might be biased against pathogens associated 
with a short duration of symptoms. Additionally, we used 
a modiﬁ ed severity score that only partly recapitulates a 
score derived from rotavirus studies and may not be 
generalisable. Therefore, we also looked at the subset of 
diarrhoea associated with dysentery, dehydration, or 
hospital admission in addition to looking at speciﬁ c 
diarrhoeal syndromes. Finally, the diagnostic approach 
used a diverse set of detection methods with diﬀ ering 
performance characteristics. It is possible, for example, 
that culture for bacterial pathogens is insensitive and was 
aﬀ ected by the frequent use of antibiotics for diarrhoea in 
these settings, such that the use of culture for detection 
may have resulted in underestimates of bacterial 
presence. Molecular testing, in particular quantiﬁ cation 
of pathogen load and quantitative analysis, could revise 
estimates of the burden of diarrhoea for these organisms.35
The longitudinal nature of this study allowed us to look 
at causes of diarrhoea in ways that are not possible with 
other study designs, including use of unbiased estimates 
of causes of diarrhoea at the community level and 
evaluation of assumptions about appropriate control 
specimens.36 Detection of pathogens in non-diarrhoeal 
stool samples might represent convalescent excretion of 
certain pathogens rather than true asymptomatic infection, 
in which case we may underestimate the burden of 
diarrhoea associated with these organisms. Malnourished 
children may be particularly likely to have prolonged 
excretion of enteropathogens. However, controlling for 
nutritional status did not appreciably alter AF estimates.
This study documents a diverse range of pathogens 
associated with community diarrhoea in children in low-
income and middle-income countries, which contrasts 
with the smaller set of pathogens associated with severe 
diarrhoea. The hierarchy of pathogen-speciﬁ c diarrhoea 
varied between sites and high rates of enteropathogens 
were detected in non-diarrhoeal samples. 
Consistent with previous studies,2,3 a high burden of 
childhood diarrhoea was attributed to rotavirus, ST-
ETEC, Shigella spp, and Cryptosporidium spp. However, 
our results suggest that Campylobacter spp, norovirus 
GII, and astrovirus also contribute substantially to the 
burden of diarrhoea in children. 
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